106 related articles for article (PubMed ID: 15744170)
1. Multiplexed analysis of serum cytokines as biomarkers in squamous cell carcinoma of the head and neck patients.
Hathaway B; Landsittel DP; Gooding W; Whiteside TL; Grandis JR; Siegfried JM; Bigbee WL; Ferris RL
Laryngoscope; 2005 Mar; 115(3):522-7. PubMed ID: 15744170
[TBL] [Abstract][Full Text] [Related]
2. Early detection of head and neck cancer: development of a novel screening tool using multiplexed immunobead-based biomarker profiling.
Linkov F; Lisovich A; Yurkovetsky Z; Marrangoni A; Velikokhatnaya L; Nolen B; Winans M; Bigbee W; Siegfried J; Lokshin A; Ferris RL
Cancer Epidemiol Biomarkers Prev; 2007 Jan; 16(1):102-7. PubMed ID: 17220337
[TBL] [Abstract][Full Text] [Related]
3. Aberrant cytokine expression in serum of patients with adenoid cystic carcinoma and squamous cell carcinoma of the head and neck.
Hoffmann TK; Sonkoly E; Homey B; Scheckenbach K; Gwosdz C; Bas M; Chaker A; Schirlau K; Whiteside TL
Head Neck; 2007 May; 29(5):472-8. PubMed ID: 17111427
[TBL] [Abstract][Full Text] [Related]
4. Relationships between regulatory T cells and CD8+ effector populations in patients with squamous cell carcinoma of the head and neck.
Chikamatsu K; Sakakura K; Whiteside TL; Furuya N
Head Neck; 2007 Feb; 29(2):120-7. PubMed ID: 17103408
[TBL] [Abstract][Full Text] [Related]
5. [Cytogenetic and hormonal changes in head and neck squamous cell cancer patients: potential biomarkers for functional approaches in surgical oncology].
Remenár E
Magy Onkol; 2009 Jun; 53(2):157-64. PubMed ID: 19581182
[TBL] [Abstract][Full Text] [Related]
6. Association between squamous cell carcinoma of the head and neck and serum folate and homocysteine.
Eleftheriadou A; Chalastras T; Ferekidou E; Yiotakis I; Kyriou L; Tzagarakis M; Ferekidis E; Kandiloros D
Anticancer Res; 2006; 26(3B):2345-8. PubMed ID: 16821614
[TBL] [Abstract][Full Text] [Related]
7. Outcome analysis of patients with squamous cell carcinoma of the head and neck and hepatitis C virus.
Hunt J; Hagan J; Nobles J; Wold C; Fazekas-May M; Gilbert J; Friedlander PL
Laryngoscope; 2005 Oct; 115(10):1882-6. PubMed ID: 16222215
[TBL] [Abstract][Full Text] [Related]
8. Serum protein profile analysis following definitive treatment in patients with head and neck squamous cell carcinoma.
Gourin CG; Moretz WH; Weinberger PM; Xia ZS; Liu Z; Terris DJ; Adam BL
Arch Otolaryngol Head Neck Surg; 2007 Nov; 133(11):1125-30. PubMed ID: 18025317
[TBL] [Abstract][Full Text] [Related]
9. Associations between XPC expression, genotype, and the risk of head and neck cancer.
Yang M; Kang MJ; Choi Y; Kim CS; Lee SM; Park CW; Lee HS; Tae K
Environ Mol Mutagen; 2005 May; 45(4):374-9. PubMed ID: 15657918
[TBL] [Abstract][Full Text] [Related]
10. Alterations in the frequency of dendritic cell subsets in the peripheral circulation of patients with squamous cell carcinomas of the head and neck.
Hoffmann TK; Müller-Berghaus J; Ferris RL; Johnson JT; Storkus WJ; Whiteside TL
Clin Cancer Res; 2002 Jun; 8(6):1787-93. PubMed ID: 12060618
[TBL] [Abstract][Full Text] [Related]
11. Gamma-delta T-cells in patients with squamous cell carcinoma of the head and neck.
Bas M; Bier H; Schirlau K; Friebe-Hoffmann U; Scheckenbach K; Balz V; Whiteside TL; Hoffmann TK
Oral Oncol; 2006 Aug; 42(7):691-7. PubMed ID: 16527515
[TBL] [Abstract][Full Text] [Related]
12. Serum concentrations of interleukin-8, vascular endothelial growth factor, and epidermal growth factor receptor in patients with squamous cell cancer of the head and neck.
Gokhale AS; Haddad RI; Cavacini LA; Wirth L; Weeks L; Hallar M; Faucher J; Posner MR
Oral Oncol; 2005 Jan; 41(1):70-6. PubMed ID: 15598588
[TBL] [Abstract][Full Text] [Related]
13. Serum biomarkers in head and neck squamous cell cancer.
Kaskas NM; Moore-Medlin T; McClure GB; Ekshyyan O; Vanchiere JA; Nathan CA
JAMA Otolaryngol Head Neck Surg; 2014 Jan; 140(1):5-11. PubMed ID: 24232368
[TBL] [Abstract][Full Text] [Related]
14. Effects of ERCC1 expression in peripheral blood on the risk of head and neck cancer.
Yang M; Kim WH; Choi Y; Lee SH; Kim KR; Lee HS; Tae K
Eur J Cancer Prev; 2006 Jun; 15(3):269-73. PubMed ID: 16679872
[TBL] [Abstract][Full Text] [Related]
15. Increased aberrance of cytokine expression in plasma of patients with more advanced squamous cell carcinoma of the head and neck.
Lathers DM; Young MR
Cytokine; 2004 Mar; 25(5):220-8. PubMed ID: 15036248
[TBL] [Abstract][Full Text] [Related]
16. Expression of p63, COX-2, EGFR and beta-catenin in smokers and patients with squamous cell carcinoma of the head and neck reveal variations in non-neoplastic tissue and no obvious changes in smokers.
Boldrup L; Coates PJ; Hedberg Y; Sjöström B; Dahlqvist A; Nylander K
Int J Oncol; 2005 Dec; 27(6):1661-7. PubMed ID: 16273222
[TBL] [Abstract][Full Text] [Related]
17. Soluble CD44v6 is not a sensitive tumor marker in patients with head and neck squamous cell cancer.
Andratschke M; Chaubal S; Pauli C; Mack B; Hagedorn H; Wollenberg B
Anticancer Res; 2005; 25(4):2821-6. PubMed ID: 16080532
[TBL] [Abstract][Full Text] [Related]
18. Alterations in the T-cell receptor variable beta gene-restricted profile of CD8+ T lymphocytes in the peripheral circulation of patients with squamous cell carcinoma of the head and neck.
Albers AE; Visus C; Tsukishiro T; Ferris RL; Gooding W; Whiteside TL; De Leo AB
Clin Cancer Res; 2006 Apr; 12(8):2394-403. PubMed ID: 16638844
[TBL] [Abstract][Full Text] [Related]
19. Serum nitric oxide levels in patients with head and neck squamous cell carcinoma.
Kizilay A; Kalcioğlu MT; Ozuğurlu F; Ozyurt H; Aladağ I; Ozturan O; Akyol O
Kulak Burun Bogaz Ihtis Derg; 2007; 17(3):148-51. PubMed ID: 17873505
[TBL] [Abstract][Full Text] [Related]
20. Defining cancer cachexia in head and neck squamous cell carcinoma.
Richey LM; George JR; Couch ME; Kanapkey BK; Yin X; Cannon T; Stewart PW; Weissler MC; Shores CG
Clin Cancer Res; 2007 Nov; 13(22 Pt 1):6561-7. PubMed ID: 18006755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
